`
`Paper No. ___
`Filed: May 22, 2017
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`_____________________________
`
`
`MYLAN PHARMACEUTICALS INC., TEVA PHARMACEUTICALS USA,
`INC. and AKORN INC.,1
`Petitioners,
`
`v.
`
`ALLERGAN, INC.
`Patent Owner.
`
`_____________________________
`
`Case IPR2016-01127 (US 8,685,930 B2)
`Case IPR2016-01128 (US 8,629,111 B2)
`Case IPR2016-01129 (US 8,624,556 B2)
`Case IPR2016-01130 (US 8,633,162 B2)
`Case IPR2016-01131 (US 8,648,048 B2)
`Case IPR2016-01132 (US 9,248,191 B2)
`_____________________________
`
`PETITIONER’S NOTICE OF DEPOSITION OF
`ROBERT S. MANESS, PH.D.
`
`
`
`
`1 Cases IPR2017-00576 and IPR2017-00594, IPR2017-00578 and IPR2017 -
`00596, IPR2017 -00579 and IPR2017-00598, IPR2017 -00583 and IPR2017-
`00599, IPR2017-00585 and IPR2017-00600, and IPR2017 -00586 and IPR2017-
`00601, have respectively been joined with the captioned proceedings. The word-
`for-word identical paper is filed in each proceeding identified in the caption
`pursuant to the Board’s Scheduling Order (Paper 10).
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.53, Petitioner Mylan Pharmaceuticals Inc., by
`
`and through its attorneys, will conduct examination by deposition of Robert S.
`
`Maness, Ph.D. Dr. Maness’s deposition will take place commencing at 9:30AM
`
`(local time) on May 31, 2017, continuing day-to-day if necessary, at the offices of
`
`Carlson Caspers, 225 South Sixth Street, Suite 7500, Minneapolis, MN 55402 .
`
`The deposition will be taken before a Notary Public or other officer authorized by
`
`law to administer oaths and will be recorded using stenographic means. The
`
`arrangement for the reporter will be made by counsel for Petitioners.
`
`
`
`Dated: May 22, 2017
`
`
`
`
`
`
`Respectfully submitted,
`
`/ Steven W. Parmelee /
` Steven W. Parmelee
` Reg. No. 31,990
`
`
`
`
`
`
`-1-
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`This is to certify that I caused to be served a true and correct copy of the
`
`foregoing Petitioners’ Notice of Deposition of Robert S. Maness, Ph.D., on this
`
`22nd day of May, 2017, on the Patent Owner at the correspondence address of the
`
`Patent Owner as follows:
`
`Dorothy P. Whelan
`Michael Kane
`Susan Morrison Colletti
`Robert M. Oakes
`Fish & Richardson P.C.
`3200 RBC Plaza
`60 South Sixth Street
`Minneapolis, MN 55402
`Email: IPR13351-0008IP1@fr.com
`Email: IPR13351-0008IP2@fr.com
`Email: IPR13351-0008IP3@fr.com
`Email: IPR13351-0008IP4@fr.com
`Email: IPR13351-0008IP5@fr.com
`Email: IPR13351-0008IP6@fr.com
`Email: PTABInbound@fr.com
`
`And on the remaining petitioners as follows:
`
`
`Gary Speier
`Mark Schuman
`CARLSON, CASPERS, VANDENBURGH,
`LINDQUIST & SCHUMAN, P.A.
`225 South Sixth Street, Suite 4200
`Minneapolois, MN 55402
`Email: gspeier@carlsoncaspers.com
`Email: mschuman@carlsoncaspers.com
`Attorneys for Teva Pharmaceuticals USA, Inc.
`
`
`
`-2-
`
`
`
`Michael Dzwonczyk
`Azadeh Kokabi
`Travis Ribar
`SUGHRUE MION, PLLC
`2100 Pennsylvania Ave., NW
`Washington, DC 20037
`Email: mdzwonczyk@sughrue.com
`Email: akokabi@sughrue.com
`Email: tribar@sughrue.com
`Attorneys for Akorn Inc.
`
`
`
`
`
`Dated: May 22, 2017
`
`
`
`
`
`
`Respectfully submitted,
`
`/ Steven W. Parmelee /
` Steven W. Parmelee, Lead Counsel
` Reg. No. 31,990
`
`
`
`
`
`-3-
`
`